Reporting Manager
First Trust Capital Management L.P.
Symbol
DMAA
Shares outstanding
33,495,981 shares
Disclosed Ownership
2,066,702 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 17:24:08 UTC
Date of event
31 Mar 2025

Quoteable Key Fact

"First Trust Capital Management L.P. disclosed 6.2% ownership in Drugs Made In America Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (DMAA) on 31 Mar 2025."

Quick Takeaways

  • First Trust Capital Management L.P. filed SCHEDULE 13G for Drugs Made In America Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (DMAA).
  • Disclosed ownership: 6.2%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 17:24.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
First Trust Merger Arbitrage Fund 5.3% 1,781,724 1,781,724 0 /s/ Joy Ausili Trustee, Vice President and Assistant Secretary
First Trust Capital Management L.P. 6.2% 2,066,702 2,066,702 0 /s/ Chad Eisenberg Chief Operating Officer
First Trust Capital Solutions L.P. 6.2% 2,066,702 2,066,702 0 /s/ Chad Eisenberg Chief Operating Officer
FTCS Sub GP LLC 6.2% 2,066,702 2,066,702 0 /s/ Chad Eisenberg Chief Operating Officer